Addiction Medicine: Beyond the Abstract
By American Society of Addiction Medicine
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 66
Description
Learn more about the perspectives behind formal research articles! In Journal of Addiction Medicine: Beyond the Abstract, hosts Shawn McNeil and Zach Caruso interview authors recently published in the Journal of Addiction Medicine, detailing their research process, summarizing key findings from their work, and identifying future areas of research.
Hosted by Journal Podcast Editor, Shawn McNeil, MD, and ASAM Media Manager Zach Caruso.
| Episode | Date |
|---|---|
|
Episode Rewind | Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative
|
Oct 02, 2026 |
|
Medication Approaches for Patients With Opioid Use Disorders: Differences Between Primary Care Clinics and Specialty Addiction Treatment Programs
|
Sep 17, 2026 |
|
Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds
|
Sep 04, 2026 |
|
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique
|
Aug 20, 2026 |
|
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine
|
Aug 07, 2026 |
|
The Role of Childhood Trauma in Chronic Pain and Substance Use Among Individuals Receiving Methadone Treatment for Opioid Use Disorder
|
Jul 24, 2026 |
|
Special Episode: A Discussion on the Emerging Concept of Fetal Fentanyl Syndrome
|
Jul 10, 2026 |
|
Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review
|
Jun 25, 2026 |
|
Episode Rewind | Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem
|
Jun 11, 2026 |
|
Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial
|
May 29, 2026 |
|
Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA
|
May 14, 2026 |
|
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings
|
Apr 10, 2026 |
|
Characterization of a Young Adult Sample Accessing Buprenorphine Via Telehealth in Philadelphia, PA
|
Mar 26, 2026 |
|
Episode Rewind | From Submission to Success: Insider Tips for Getting Your Addiction Content Published
|
Feb 21, 2026 |
|
Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine
|
Feb 06, 2026 |
|
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders
|
Jan 26, 2026 |
|
Navigating Choices: Pregnancy Options Counseling Experiences in Individuals With Opioid Use Disorder
|
Jan 08, 2026 |
|
Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes
|
Dec 11, 2025 |
|
Non-medical Mephentermine Use: A Systematic Review of Literature
|
Nov 28, 2025 |
|
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service
|
Nov 13, 2025 |
|
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative
|
Sep 18, 2025 |
|
Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs
|
Aug 28, 2025 |
|
Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem
|
Jul 11, 2025 |
|
Post Void Residuals: Medications for Opioid Use Disorder, Patient Outcomes, and How Not to Get Fooled by Urine Toxicology Results
|
Jun 26, 2025 |
|
The First 100 Days: The Trump Administration and Changes to Addiction Policy
|
Jun 12, 2025 |
|
From Submission to Success: Insider Tips for Getting Your Addiction Content Published
|
May 29, 2025 |
|
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder
|
May 16, 2025 |
|
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis
|
May 01, 2025 |
|
Withdrawal Signs and Symptoms Among Patients Positive for Fentanyl With and Without Xylazine
|
Apr 17, 2025 |
|
Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers
|
Mar 20, 2025 |
|
Integration of a Community Opioid Treatment Program Into a Federally Qualified Health Center
|
Jan 30, 2025 |
|
Expert Panel Consensus of the Effectiveness and Implementation of Models to Support Posthospitalization Care Transitions for People With Substance Use Disorders
|
Dec 13, 2024 |
|
The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients
|
Nov 04, 2024 |
|
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
|
Oct 08, 2024 |
|
Hospital Initiatives to Transition SUD Patients from Acute Care to Community-based Services
|
Jun 06, 2024 |
|
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022
|
Apr 24, 2024 |
|
Exploring the Impact of Opioid Settlements on Addiction Medicine
|
Jan 23, 2024 |
|
Association of Urine Fentanyl Concentration With Severity of Opioid Withdrawal Among Patients Presenting to the Emergency Department
|
Dec 12, 2023 |
|
Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder
|
Oct 18, 2023 |
|
Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder
|
Oct 18, 2023 |
|
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study
|
Aug 16, 2023 |
|
Meet New JAM Editor-in-Chief, David A. Fiellin, MD, FASAM
|
Jul 10, 2023 |
|
Surveillance System for Opioid-Associated Amnestic Syndrome
|
Aug 16, 2022 |
|
HIV Preexposure Prophylaxis by Buprenorphine Prescribers
|
Apr 14, 2022 |
|
Racial-ethnic Differences in Misuse of Prescription Medications
|
Feb 17, 2022 |
|
Rejection of Referrals Based on Substance Use Diagnosis and Treatment
|
Aug 31, 2021 |
|
Patient-Centeredness of Addiction Treatment Intake
|
May 30, 2021 |
|
Sex Differences Among Adults With Opioid Use Disorder
|
Apr 29, 2021 |
|
Avoiding NICU for Newborns With Neonatal Opioid Withdrawal Syndrome
|
Feb 02, 2021 |
|
Computerized CBT for Substance Use Disorders
|
Feb 02, 2021 |
|
Opioid Overdose in the Hospital Setting: A Systematic Review
|
Apr 16, 2020 |
|
Integrating Reproductive Health Services into Opioid Treatment Facilities
|
Jan 23, 2020 |
|
Technology Use Among Patients in Inpatient Medically Managed Withdrawal
|
Oct 08, 2019 |
|
Opioid Agonist Treatment in Postpartum Period During Incarceration
|
Jul 29, 2019 |
|
Integrating Reproductive and Sexual Health Services for Women in Opioid Treatment Programs
|
May 28, 2019 |
|
Hospital-Based Addiction Care: The Improving Addiction Care Team (IMPACT)
|
Apr 09, 2019 |
|
Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients
|
Mar 13, 2019 |
|
Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios
|
Nov 27, 2018 |
|
Buprenorphine Treatment for Adolescents and Young Adults
|
Sep 06, 2018 |
|
Nicotine Content in E-cigarette liquid: often not as labeled
|
Jun 29, 2018 |
|
Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal
|
May 15, 2018 |
|
Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles
|
Apr 03, 2018 |
|
Improving Opioid Addiction Treatment for Pregnant Women
|
Feb 16, 2018 |
|
Addressing Stigma in medication Treatment of Adolescents with Opioid Use Disorder
|
Jan 03, 2018 |
|
The Unexpected Urine Test: A Matter Far From Simple
|
Jan 03, 2018 |
|
Post-Cesarean Analgesia in Women on opioid agonists to treat Opiate Use Disorder
|
Dec 19, 2017 |